Hybrid revascularization comparable to conventional CABG

In a propensity-matched analysis, Rosenblum and colleagues found that hybrid revascularization as compared with coronary artery bypass grafting with either single or bilateral internal mammary artery grafts was superior in terms of secondary short-term outcomes (e.g. renal failure, prolonged mechanical ventilation, blood transfusions) and postoperative length-of-stay. After a median of 2.8 years of follow-up, there were no differences in all-cause mortality between any of the groups. It should be noted that groups were small (n=306 each) and that randomized data is imperative before the more widespread adoption of hybrid revascularization.